NovoCure Ltd - ORD SHS (NVCR)

Historical Portfolio Holders from Q4 2015 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / ORD SHS
Shares, excl. options Q3 2024
92.9M
Holdings value Q3 2024
$1.45B
Value change Q3 2024
-$11.2M
Grand Portfolio weight change Q3 2024
0%
Number of holders
218
Number of buys Q3 2024
84
Number of sells Q3 2024
-107
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 92.9M $1.45B -$11.2M $15.63 219
2024 Q2 92.9M $1.59B +$79.8M $17.13 229
2024 Q1 89.1M $1.39B -$17.8M $15.63 230
2023 Q4 90.5M $1.35B -$14.6M $14.93 212
2023 Q3 91.1M $1.47B -$109M $16.15 219
2023 Q2 90.3M $3.75B +$42.7M $41.50 252
2023 Q1 89.3M $5.37B +$283M $60.14 292
2022 Q4 84.4M $6.19B -$14.4M $73.35 302
2022 Q3 83.3M $6.33B +$224M $75.98 293
2022 Q2 80.3M $5.58B -$45.6M $69.50 296
2022 Q1 81.2M $6.72B +$212M $82.85 296
2021 Q4 79M $5.93B +$46.3M $75.08 293
2021 Q3 77.5M $9B -$79.9M $116.17 303
2021 Q2 77.6M $17.2B +$569M $221.82 352
2021 Q1 75.2M $9.94B +$139M $132.18 315
2020 Q4 74.2M $12.8B +$249M $173.04 349
2020 Q3 73.2M $8.15B +$549M $111.31 276
2020 Q2 69.1M $4.1B -$81.8M $59.30 257
2020 Q1 70.4M $4.74B +$74.6M $67.34 261
2019 Q4 69.1M $5.83B +$164M $84.27 256
2019 Q3 66.7M $4.99B +$90.6M $74.78 234
2019 Q2 65.8M $4.16B +$194M $63.23 192
2019 Q1 63.5M $3.06B +$299M $48.17 196
2018 Q4 57.3M $1.92B +$53.7M $33.48 163
2018 Q3 54.7M $2.87B +$204M $52.40 177
2018 Q2 51.8M $1.62B +$259M $31.30 163
2018 Q1 44M $959M +$149M $21.80 131
2017 Q4 37.4M $756M +$13.1M $20.20 126
2017 Q3 36.8M $731M +$98.7M $19.85 101
2017 Q2 31.9M $551M +$204M $17.30 82
2017 Q1 20.2M $164M +$27M $8.10 69
2016 Q4 20.1M $158M +$10.1M $7.85 75
2016 Q3 18.8M $161M -$21.8M $8.54 62
2016 Q2 19.4M $227M +$67.5M $11.67 65
2016 Q1 13.6M $197M +$32.4M $14.48 56
2015 Q4 11.3M $249M +$249M $22.36 47